|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 165 for Tnfsf10

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
1.44s

Categories

Category: Publication
Type Details Score
Publication
First Author: Collison A
Year: 2014
Journal: Am J Respir Cell Mol Biol
Title: Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease.
Volume: 51
Issue: 1
Pages: 86-93
Publication
First Author: Dadey RE
Year: 2021
Journal: Immunohorizons
Title: Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.
Volume: 5
Issue: 1
Pages: 48-58
Publication
First Author: Wiley SR
Year: 1995
Journal: Immunity
Title: Identification and characterization of a new member of the TNF family that induces apoptosis.
Volume: 3
Issue: 6
Pages: 673-82
Publication
First Author: Sedger LM
Year: 2002
Journal: Eur J Immunol
Title: Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice.
Volume: 32
Issue: 8
Pages: 2246-54
Publication
First Author: Zheng SJ
Year: 2004
Journal: J Clin Invest
Title: Critical roles of TRAIL in hepatic cell death and hepatic inflammation.
Volume: 113
Issue: 1
Pages: 58-64
Publication
First Author: Cretney E
Year: 2005
Journal: Immunol Cell Biol
Title: TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.
Volume: 83
Issue: 5
Pages: 511-9
Publication
First Author: Lamhamedi-Cherradi SE
Year: 2003
Journal: Nat Immunol
Title: Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice.
Volume: 4
Issue: 3
Pages: 255-60
Publication
First Author: Zheng SJ
Year: 2004
Journal: J Immunol
Title: Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice.
Volume: 173
Issue: 9
Pages: 5652-8
Publication
First Author: Hoffmann O
Year: 2007
Journal: J Clin Invest
Title: TRAIL limits excessive host immune responses in bacterial meningitis.
Volume: 117
Issue: 7
Pages: 2004-13
Publication
First Author: Lamhamedi-Cherradi SE
Year: 2003
Journal: Diabetes
Title: Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes.
Volume: 52
Issue: 9
Pages: 2274-8
Publication
First Author: Ikeda T
Year: 2010
Journal: J Immunol
Title: Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
Volume: 185
Issue: 9
Pages: 5259-67
Publication
First Author: Cretney E
Year: 2003
Journal: J Exp Med
Title: Normal thymocyte negative selection in TRAIL-deficient mice.
Volume: 198
Issue: 3
Pages: 491-6
Publication
First Author: Hirsova P
Year: 2017
Journal: Hepatol Commun
Title: TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity.
Volume: 1
Issue: 7
Pages: 648-662
Publication
First Author: McGrath EE
Year: 2011
Journal: J Leukoc Biol
Title: TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation.
Volume: 90
Issue: 5
Pages: 855-65
Publication
First Author: Girkin JL
Year: 2017
Journal: Am J Physiol Lung Cell Mol Physiol
Title: TRAIL signaling is proinflammatory and proviral in a murine model of rhinovirus 1B infection.
Volume: 312
Issue: 1
Pages: L89-L99
Publication
First Author: Unsinger J
Year: 2010
Journal: J Immunol
Title: Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism.
Volume: 184
Issue: 12
Pages: 6766-72
Publication
First Author: Hubert KE
Year: 2009
Journal: Am J Pathol
Title: TRAIL-deficient mice exhibit delayed regression of retinal neovascularization.
Volume: 175
Issue: 6
Pages: 2697-708
Publication
First Author: Borges M
Year: 2011
Journal: Clin Exp Immunol
Title: The death-promoting molecule tumour necrosis factor-related apoptosis inducing ligand (TRAIL) is not required for the development of peripheral lymphopenia or granuloma necrosis during infection with virulent Mycobacterium avium.
Volume: 164
Issue: 3
Pages: 407-16
Publication
First Author: Shrestha B
Year: 2012
Journal: J Virol
Title: CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons.
Volume: 86
Issue: 17
Pages: 8937-48
Publication
First Author: Cartland SP
Year: 2017
Journal: Sci Rep
Title: Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice.
Volume: 7
Issue: 1
Pages: 1898
Publication
First Author: Brincks EL
Year: 2011
Journal: J Immunol
Title: The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.
Volume: 187
Issue: 9
Pages: 4581-8
Publication
First Author: Schmaltz C
Year: 2002
Journal: Nat Med
Title: T cells require TRAIL for optimal graft-versus-tumor activity.
Volume: 8
Issue: 12
Pages: 1433-7
Publication
First Author: Griffith TS
Year: 2007
Journal: J Immunol
Title: Apoptotic cells induce tolerance by generating helpless CD8+ T cells that produce TRAIL.
Volume: 178
Issue: 5
Pages: 2679-87
Publication
First Author: Lin YC
Year: 2014
Journal: PLoS One
Title: Characterization of the role of tumor necrosis factor apoptosis inducing ligand (TRAIL) in spermatogenesis through the evaluation of trail gene-deficient mice.
Volume: 9
Issue: 4
Pages: e93926
Publication
First Author: Badovinac VP
Year: 2006
Journal: J Immunol
Title: TRAIL deficiency delays, but does not prevent, erosion in the quality of "helpless" memory CD8 T cells.
Volume: 177
Issue: 2
Pages: 999-1006
Publication
First Author: Gurung P
Year: 2011
Journal: J Immunol
Title: Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent.
Volume: 187
Issue: 5
Pages: 2148-54
Publication
First Author: Lavenu A
Year: 1996
Journal: Genomics
Title: Genomic structure and precise mapping of a thymic regulatory region on mouse chromosome 17 revealed by a c-myc transgene insertion.
Volume: 34
Issue: 3
Pages: 381-8
Publication
First Author: Walczak H
Year: 1999
Journal: Nat Med
Title: Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Volume: 5
Issue: 2
Pages: 157-63
Publication
First Author: Yen ML
Year: 2008
Journal: Mol Immunol
Title: TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
Volume: 45
Issue: 8
Pages: 2205-13
Publication
First Author: Bucks CM
Year: 2009
Journal: J Immunol
Title: Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion.
Volume: 182
Issue: 11
Pages: 6697-708
Publication
First Author: Chyuan IT
Year: 2019
Journal: Mucosal Immunol
Title: TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway.
Volume: 12
Issue: 4
Pages: 980-989
Publication
First Author: Hayashi Y
Year: 2021
Journal: PLoS One
Title: Virus-infection in cochlear supporting cells induces audiosensory receptor hair cell death by TRAIL-induced necroptosis.
Volume: 16
Issue: 11
Pages: e0260443
Publication
First Author: Krishnan A
Year: 2024
Journal: Sci Rep
Title: Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) deletion in myeloid cells augments cholestatic liver injury.
Volume: 14
Issue: 1
Pages: 2145
Publication
First Author: Haynes NM
Year: 2010
Journal: J Immunol
Title: CD11c+ dendritic cells and B cells contribute to the tumoricidal activity of anti-DR5 antibody therapy in established tumors.
Volume: 185
Issue: 1
Pages: 532-41
Publication
First Author: Turchinovich G
Year: 2018
Journal: J Immunol
Title: NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL Expression.
Volume: 200
Issue: 11
Pages: 3762-3768
Publication
First Author: French LE
Year: 1999
Journal: Nat Med
Title: The TRAIL to selective tumor death.
Volume: 5
Issue: 2
Pages: 146-7
Publication
First Author: Takeda K
Year: 2002
Journal: J Exp Med
Title: Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.
Volume: 195
Issue: 2
Pages: 161-9
Publication
First Author: Kang S
Year: 2010
Journal: Endocrinology
Title: Systemic delivery of TNF-related apoptosis-inducing ligand (TRAIL) elevates levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and prevents type 1 diabetes in nonobese diabetic mice.
Volume: 151
Issue: 12
Pages: 5638-46
Publication
First Author: Cao X
Year: 2011
Journal: FASEB J
Title: The role of TRADD in TRAIL-induced apoptosis and signaling.
Volume: 25
Issue: 4
Pages: 1353-8
Publication
First Author: Di Bartolo BA
Year: 2011
Journal: Diabetologia
Title: TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe ⁻/⁻ mice.
Volume: 54
Issue: 12
Pages: 3157-67
Publication
First Author: Cartland SP
Year: 2014
Journal: PLoS One
Title: TRAIL deficiency contributes to diabetic nephropathy in fat-fed ApoE-/- mice.
Volume: 9
Issue: 3
Pages: e92952
Publication
First Author: Hameed AG
Year: 2012
Journal: J Exp Med
Title: Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension.
Volume: 209
Issue: 11
Pages: 1919-35
Publication
First Author: Takeda K
Year: 2001
Journal: Cell Immunol
Title: Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
Volume: 214
Issue: 2
Pages: 194-200
Publication
First Author: Zerafa N
Year: 2005
Journal: J Immunol
Title: Cutting edge: TRAIL deficiency accelerates hematological malignancies.
Volume: 175
Issue: 9
Pages: 5586-90
Publication
First Author: Hamilton SE
Year: 2006
Journal: Nat Immunol
Title: The generation of protective memory-like CD8+ T cells during homeostatic proliferation requires CD4+ T cells.
Volume: 7
Issue: 5
Pages: 475-81
Publication
First Author: Grosse-Wilde A
Year: 2008
Journal: J Clin Invest
Title: TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development.
Volume: 118
Issue: 1
Pages: 100-10
Publication
First Author: Beraza N
Year: 2009
Journal: J Exp Med
Title: Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.
Volume: 206
Issue: 8
Pages: 1727-37
Publication
First Author: Chan J
Year: 2010
Journal: Circ Res
Title: TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner.
Volume: 106
Issue: 6
Pages: 1061-71
Publication
First Author: Ji YW
Year: 2020
Journal: Invest Ophthalmol Vis Sci
Title: HIF1α-mediated TRAIL Expression Regulates Lacrimal Gland Inflammation in Dry Eye Disease.
Volume: 61
Issue: 1
Pages: 3
Publication
First Author: Gurung P
Year: 2010
Journal: J Leukoc Biol
Title: TRAIL-expressing CD8+ T cells mediate tolerance following soluble peptide-induced peripheral T cell deletion.
Volume: 88
Issue: 6
Pages: 1217-25
Publication
First Author: Griffith TS
Year: 2011
Journal: J Immunol
Title: Systemic immunological tolerance to ocular antigens is mediated by TRAIL-expressing CD8+ T cells.
Volume: 186
Issue: 2
Pages: 791-8
Publication
First Author: Brincks EL
Year: 2008
Journal: J Immunol
Title: CD8 T cells utilize TRAIL to control influenza virus infection.
Volume: 181
Issue: 7
Pages: 4918-25
Publication
First Author: Steinwede K
Year: 2012
Journal: J Exp Med
Title: TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice.
Volume: 209
Issue: 11
Pages: 1937-52
Publication
First Author: VanOosten RL
Year: 2007
Journal: Cancer Res
Title: Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy.
Volume: 67
Issue: 24
Pages: 11980-90
Publication  
First Author: Chyuan IT
Year: 2018
Journal: Front Immunol
Title: TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.
Volume: 9
Pages: 15
Publication
First Author: Berg D
Year: 2007
Journal: Cell Death Differ
Title: Enforced covalent trimerization increases the activity of the TNF ligand family members TRAIL and CD95L.
Volume: 14
Issue: 12
Pages: 2021-34
Publication
First Author: Na IK
Year: 2010
Journal: J Clin Invest
Title: The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.
Volume: 120
Issue: 1
Pages: 343-56
Publication
First Author: Lluis JM
Year: 2010
Journal: PLoS One
Title: TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.
Volume: 5
Issue: 1
Pages: e8620
Publication
First Author: Schneider P
Year: 2003
Journal: J Biol Chem
Title: Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
Volume: 278
Issue: 7
Pages: 5444-54
Publication
First Author: Ren X
Year: 2007
Journal: Cell Death Differ
Title: Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4(+)CD25(+) regulatory T cells.
Volume: 14
Issue: 12
Pages: 2076-84
Publication
First Author: Cretney E
Year: 2008
Journal: Int Immunol
Title: No requirement for TRAIL in intrathymic negative selection.
Volume: 20
Issue: 2
Pages: 267-76
Publication
First Author: Seki N
Year: 2003
Journal: Cancer Res
Title: Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.
Volume: 63
Issue: 1
Pages: 207-13
Publication
First Author: Lindemann RK
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma.
Volume: 104
Issue: 19
Pages: 8071-6
Publication
First Author: Cretney E
Year: 2002
Journal: J Immunol
Title: Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
Volume: 168
Issue: 3
Pages: 1356-61
Publication
First Author: Iyori M
Year: 2011
Journal: J Immunol
Title: TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.
Volume: 187
Issue: 6
Pages: 3087-95
Publication
First Author: Sacks JA
Year: 2008
Journal: J Immunol
Title: TRAIL deficiency does not rescue impaired CD8+ T cell memory generated in the absence of CD4+ T cell help.
Volume: 180
Issue: 7
Pages: 4570-6
Publication
First Author: Kitahara Y
Year: 2010
Journal: Eur J Immunol
Title: Interferon-induced TRAIL-independent cell death in DNase II-/- embryos.
Volume: 40
Issue: 9
Pages: 2590-8
Publication
First Author: Corazza N
Year: 2006
Journal: J Clin Invest
Title: TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality.
Volume: 116
Issue: 9
Pages: 2493-9
Publication
First Author: Takeda K
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease.
Volume: 105
Issue: 31
Pages: 10895-900
Publication
First Author: Azahri NS
Year: 2012
Journal: J Cell Biochem
Title: Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration.
Volume: 113
Issue: 8
Pages: 2597-606
Publication
First Author: Bumdelger B
Year: 2016
Journal: PLoS One
Title: Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms.
Volume: 11
Issue: 1
Pages: e0147088
Publication
First Author: Yano T
Year: 2017
Journal: PLoS One
Title: Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.
Volume: 12
Issue: 10
Pages: e0186997
Publication
First Author: Aslan JE
Year: 2009
Journal: Mol Cell
Title: Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis.
Volume: 34
Issue: 4
Pages: 497-509
Publication
First Author: Kim JY
Year: 2011
Journal: FEBS Lett
Title: TRADD is critical for resistance to TRAIL-induced cell death through NF-κB activation.
Volume: 585
Issue: 14
Pages: 2144-50
Publication
First Author: Liu L
Year: 2012
Journal: J Immunol
Title: The calcineurin B subunit (CnB) is a new ligand of integrin αM that mediates CnB-induced Apo2L/TRAIL expression in macrophages.
Volume: 188
Issue: 1
Pages: 238-47
Publication  
First Author: Toffoli B
Year: 2016
Journal: Mediators Inflamm
Title: Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.
Volume: 2016
Pages: 6529728
Publication
First Author: Janssen EM
Year: 2005
Journal: Nature
Title: CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.
Volume: 434
Issue: 7029
Pages: 88-93
Publication
First Author: Hayakawa Y
Year: 2004
Journal: J Immunol
Title: NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy.
Volume: 172
Issue: 1
Pages: 123-9
Publication
First Author: Wiede F
Year: 2007
Journal: Eur J Immunol
Title: TNF-dependent overexpression of CCL21 is an underlying cause of progressive lymphoaccumulation in generalized lymphoproliferative disorder.
Volume: 37
Issue: 2
Pages: 351-7
Publication
First Author: Di Bartolo BA
Year: 2013
Journal: PLoS One
Title: TRAIL-deficiency accelerates vascular calcification in atherosclerosis via modulation of RANKL.
Volume: 8
Issue: 9
Pages: e74211
Publication
First Author: Smyth MJ
Year: 2005
Journal: J Exp Med
Title: NKG2D function protects the host from tumor initiation.
Volume: 202
Issue: 5
Pages: 583-8
Publication  
First Author: Takeda K
Year: 2017
Journal: Nat Commun
Title: IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting.
Volume: 8
Pages: 14607
Publication
First Author: Hequet O
Year: 2020
Journal: Eur J Immunol
Title: CD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy.
Volume: 50
Issue: 5
Pages: 725-735
Publication
First Author: Cardoso Alves L
Year: 2020
Journal: EMBO Rep
Title: Non-apoptotic TRAIL function modulates NK cell activity during viral infection.
Volume: 21
Issue: 1
Pages: e48789
Publication
First Author: Woyciechowski S
Year: 2020
Journal: Eur J Immunol
Title: NK1.1+ innate lymphoid cells in salivary glands inhibit establishment of tissue-resident memory CD8+ T cells in mice.
Volume: 50
Issue: 12
Pages: 1952-1958
Publication
First Author: Weckmann M
Year: 2007
Journal: Nat Med
Title: Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease.
Volume: 13
Issue: 11
Pages: 1308-15
Publication
First Author: Guicciardi ME
Year: 2017
Journal: Cell Death Dis
Title: Biliary tract instillation of a SMAC mimetic induces TRAIL-dependent acute sclerosing cholangitis-like injury in mice.
Volume: 8
Issue: 1
Pages: e2535
Publication
First Author: Song Y
Year: 2005
Journal: J Biol Chem
Title: The mouse cell surface protein TOSO regulates Fas/Fas ligand-induced apoptosis through its binding to Fas-associated death domain.
Volume: 280
Issue: 10
Pages: 9618-26
Publication
First Author: Capitini CM
Year: 2013
Journal: J Immunol
Title: Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis.
Volume: 190
Issue: 3
Pages: 1351-9
Publication
First Author: Smyth MJ
Year: 2005
Journal: J Exp Med
Title: Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.
Volume: 201
Issue: 12
Pages: 1973-85
Publication
First Author: Rodrigue-Gervais IG
Year: 2014
Journal: Cell Host Microbe
Title: Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival.
Volume: 15
Issue: 1
Pages: 23-35
Publication
First Author: Sanmarco LM
Year: 2021
Journal: Nature
Title: Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes.
Volume: 590
Issue: 7846
Pages: 473-479
Publication
First Author: Takeda K
Year: 2005
Journal: Blood
Title: TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver.
Volume: 105
Issue: 5
Pages: 2082-9
Publication
First Author: Abdool K
Year: 2006
Journal: J Immunol
Title: NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
Volume: 177
Issue: 4
Pages: 2575-83
Publication
First Author: Ebert G
Year: 2020
Journal: Cell Rep
Title: Targeting the Extrinsic Pathway of Hepatocyte Apoptosis Promotes Clearance of Plasmodium Liver Infection.
Volume: 30
Issue: 13
Pages: 4343-4354.e4
Publication
First Author: Gharavi AG
Year: 2004
Journal: Proc Natl Acad Sci U S A
Title: Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3.
Volume: 101
Issue: 8
Pages: 2488-93
Publication
First Author: Brady J
Year: 2004
Journal: J Immunol
Title: IL-21 induces the functional maturation of murine NK cells.
Volume: 172
Issue: 4
Pages: 2048-58
Publication
First Author: Droin NM
Year: 2003
Journal: Mol Cell Biol
Title: Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses.
Volume: 23
Issue: 21
Pages: 7638-47
Publication
First Author: Montalvo V
Year: 2009
Journal: Curr Eye Res
Title: Constitutive pro-apoptotic molecules are differentially expressed in the fetal and adult mouse eye.
Volume: 34
Issue: 4
Pages: 328-32
Publication
First Author: Pillai MR
Year: 2011
Journal: J Immunol
Title: The plasticity of regulatory T cell function.
Volume: 187
Issue: 10
Pages: 4987-97